Faster global financial news!
GLP-1 drugs
-
Walmart will provide over 250 prescription drugs, including certain GLP-1 medications, inhalers, and insulin, free of charge to its employees.
Walmart confirmed to CNBC on Tuesday that it plans to offer over 250 prescription drugs for free to its employees by 2027, including certain insulins, inhalers, and GLP-1 drugs for diabetes treatment.
-
Korea's Hanmi Pharmaceutical to launch first homegrown GLP-1 drug Eppe by year-end, potentially undercutting Wegovy and Mounjaro with estimated ₩150,000 ($111) per four-week supply.
Korea's Hanmi Pharmaceutical to launch first homegrown GLP-1 drug Eppe by year-end, potentially undercutting Wegovy and Mounjaro with estimated ₩150,000 ($111) per four-week supply.
-
Novo Nordisk unveils new growth strategy, but analysts remain skeptical about the market prospects of its GLP-1 drugs.
Novo Nordisk unveiled a strategy this week aimed at revitalizing growth, planning to diversify its product pipeline to drive expansion after the patents for its blockbuster drugs Wegovy and Ozempic ex
-
Riverwater Partners initiated a position in Stevanato Group (STVN) in Q2 2026, believing the market overreacted to the launch of oral GLP-1s.
In its Q2 2026 investor letter, the investment management company stated that STVN's stock sold off following the launch of oral GLP-1s, which many believe would end the need for injectable forms. How
-
Yahoo Finance analysis favors Eli Lilly over AbbVie for 2026 healthcare stock investment
Yahoo Finance analysis suggests Eli Lilly and Co (LLY) is a better healthcare stock buy for 2026 compared to AbbVie Inc (ABBV), citing Eli Lilly's strong growth in metabolic and obesity platforms driv
-
FedEx prioritizes healthcare logistics, eyeing GLP-1 drug market
FedEx is bolstering its business-to-business (B2B) healthcare shipping services, making it one of the company's four prioritized B2B verticals. This strategic push is aimed at capitalizing on the grow
-
Walmart will provide over 250 prescription drugs, including certain GLP-1 medications, inhalers, and insulin, free of charge to its employees.
Walmart confirmed to CNBC on Tuesday that it plans to offer over 250 prescription drugs for free to its employees by 2027, including certain insulins, inhalers, and GLP-1 drugs for diabetes treatment.
-
Korea's Hanmi Pharmaceutical to launch first homegrown GLP-1 drug Eppe by year-end, potentially undercutting Wegovy and Mounjaro with estimated ₩150,000 ($111) per four-week supply.
Korea's Hanmi Pharmaceutical to launch first homegrown GLP-1 drug Eppe by year-end, potentially undercutting Wegovy and Mounjaro with estimated ₩150,000 ($111) per four-week supply.
-
Novo Nordisk unveils new growth strategy, but analysts remain skeptical about the market prospects of its GLP-1 drugs.
Novo Nordisk unveiled a strategy this week aimed at revitalizing growth, planning to diversify its product pipeline to drive expansion after the patents for its blockbuster drugs Wegovy and Ozempic ex
-
Riverwater Partners initiated a position in Stevanato Group (STVN) in Q2 2026, believing the market overreacted to the launch of oral GLP-1s.
In its Q2 2026 investor letter, the investment management company stated that STVN's stock sold off following the launch of oral GLP-1s, which many believe would end the need for injectable forms. How
-
Yahoo Finance analysis favors Eli Lilly over AbbVie for 2026 healthcare stock investment
Yahoo Finance analysis suggests Eli Lilly and Co (LLY) is a better healthcare stock buy for 2026 compared to AbbVie Inc (ABBV), citing Eli Lilly's strong growth in metabolic and obesity platforms driv
-
FedEx prioritizes healthcare logistics, eyeing GLP-1 drug market
FedEx is bolstering its business-to-business (B2B) healthcare shipping services, making it one of the company's four prioritized B2B verticals. This strategic push is aimed at capitalizing on the grow
- No data
GLP-1 drugs
24H Trending
-
1
AI Tokens Explained: Definition, Key Projects, and Market Outlook for Artificial Intelligence Cryptocurrencies
-
2
Which Platforms Allow Bitcoin Purchases Now? A Guide to Choosing Bitcoin Trading Apps
-
3
OKX Official App Download Channels and Security Guide
-
4
Global Crypto Exchange Analysis: Largest Platforms and Best Application Choices
-
5
RAZOR Network (RAZOR) Token: Current Status and Value Analysis
-
6
Silencio (SLC) Token Analysis: Value, Market Performance, and Investment Considerations
-
7
How to Choose a Cryptocurrency Exchange: Analyzing Features and Factors of Mainstream Platforms
-
8
Can GRT (The Graph) Return to $5? Project Developments and Market Outlook Analysis
-
9
Tethereum (T99) Token Analysis: How to Trade and Exchange Listing Overview
-
10
CATHEON Token Analysis: Catheon Gaming Ecosystem Token and Its Trading Status
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
